Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerChristine Ribic, Steven Gallinger, Daniel J. Sargent et al.|New England Journal of Medicine|2003Cited by 2.1k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upGuillem Argilés, Dirk Arnold, Josep Tabernero et al.|Annals of Oncology|2020Cited by 1.3k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityBernhard Mlecnik, Jérôme Galon, Gabriela Bindea et al.|Immunity|2016Cited by 1.1k
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A. Bradley, Sandra Van Schaeybroeck, Manuel Salto‐Tellez et al.|Nature Reviews Clinical Oncology|2017Cited by 241
Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based ChemotherapyThierry Lecomte, Pierre Laurent‐Puig, Jean‐Marc Ferraz et al.|Clinical Cancer Research|2004Cited by 241